- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Jeff White: Collaboration Is Key to Combatting Opioid Epidemic
Jeff White, PharmD, MS, staff vice president, Anthem, discusses what role Anthem has in addressing the opioid epidemic, as well as how important collaboration with other stakeholders is for addressing the epidemic.
Jeff White, PharmD, MS, staff vice president, Anthem, discusses what role Anthem has in addressing the opioid epidemic, as well as how important collaboration with other stakeholders is for addressing the epidemic.
TranscriptAs a payer, what role do you have in addressing the opioid epidemic?
Anthem has taken a national leadership role in addressing the opioid abuse epidemic. We set out a goal of reducing opioid use by 30% by 2019 from its peak in 2012. We’ve achieved that goal 2 years early. In fact, we’ve achieved over a 40% reduction in opioid use since the peak in 2012. So, Anthem has an important role in helping to address the opioid abuse epidemic.
How important is it to collaborate with other stakeholders in order to ensure success with these different initiatives?
This epidemic is so large and vast and complicated, it’s going to take effort from a number of different stakeholders to help address this epidemic. For example, the government, regulatory agencies, health plans such as Anthem, PBMs [pharmacy benefit managers], physicians, educating patients, are all necessary to help address the opioid abuse epidemic.
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Accessing pediatric dermatology care is challenging due to a shortage of specialists and general dermatologists' reluctance to treat children, but increasing their comfort level with seeing children could help bridge the gap, explained Elizabeth Garcia Creighton, of University of Colorado School of Medicine.
Read More
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
